Header cover image

German Healthcare Undervalued based on future growth

Results

3

1 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

3 companies

Medios

Market Cap: €379.5m

Supplies specialty pharmaceutical drugs primarily in Germany.

ILM1

€14.88

7D

21.6%

1Y

0%

M1 Kliniken

Market Cap: €272.0m

Provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia.

M12

€14.66

7D

1.4%

1Y

-10.9%

Stratec

Market Cap: €263.8m

Provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally.

New

SBS

€21.70

7D

0.7%

1Y

-29.7%